New therapeutic principles in dyslipidaemia: Focus on LDL and Lp(a) lowering drugs

QR Code

New therapeutic principles in dyslipidaemia: Focus on LDL and Lp(a) lowering drugs

Dyslipidaemias play a key role in determining cardiovascular risk; the discovery of statins has contributed a very effective approach. However, many patients do not achieve, at the maximal tolerated dose, the recommended goals for low-density lipoprotein-cholesterol (LDL-C), non-high-density lipopro...

Full description

Bibliographic Details
Main Authors:	Norata, Giuseppe, Ballantyne, C., Catapano, A.
Format:	Journal Article
Published:	Oxford University Press 2013
Online Access:	http://hdl.handle.net/20.500.11937/55365

Similar Items

Statins and periodontal inflammation: A pleiotropic effect of statins or a pleiotropic effect of LDL-cholesterol lowering?
by: Norata, Giuseppe, et al.
Published: (2014)

Gene silencing approaches for the management of dyslipidaemia
by: Norata, Giuseppe, et al.
Published: (2013)

LOX-1, OxLDL, and atherosclerosis
by: Pirillo, A., et al.
Published: (2013)

New therapeutic principles for familial hypercholesterolemia
by: Norata, Giuseppe
Published: (2014)

Fibronectin extra domain A stabilises atherosclerotic plaques in apolipoprotein E and in LDL-receptor-deficient mice
by: Pulakazhi Venu, V., et al.
Published: (2015)

New developments in convergence of wavelet expansion of functions Lᴾ (R²), Sobolev space Hˢ (R²) and Lᴾ (S²)
by: Shamsah, Raghad Sahib Abbas
Published: (2019)

Leonurine: A new comer in the natural compounds affecting atherosclerosis
by: Norata, Giuseppe, et al.
Published: (2012)

Biology of proprotein convertase subtilisin kexin 9: Beyond low-density lipoprotein cholesterol lowering
by: Norata, Giuseppe, et al.
Published: (2016)

Proprotein convertase subtilisin/kexin type 9 (PCSK9): From structure-function relation to therapeutic inhibition
by: Tibolla, G., et al.
Published: (2011)

Perceptions of therapeutic principles in a therapeutic community
by: Capone, Georgina, et al.
Published: (2017)

Dyslipidaemia In Patients With Type 2 Diabetes Mellitus.
by: Eid, M, et al.
Published: (2003)

Re: Managing dyslipidaemia for the primary prevention of cardiovascular disease
by: Hippisley-Cox, Julia
Published: (2018)

HDL and adaptive immunity: A tale of lipid rafts
by: Norata, Giuseppe, et al.
Published: (2012)

PCSK9 inhibition in statin-intolerant HeFH patients: What's new?
by: Casula, M., et al.
Published: (2017)

On group-wise ℓp regularization: Theory and efficient algorithms
by: Pham, DucSon
Published: (2015)

Organic and inorganic passivation performance on electroless nickel (LP)
by: Abdul Malick, Sharqiyah
Published: (2007)

The CD1d-natural killer T cell axis in atherosclerosis
by: Bondarenko, S., et al.
Published: (2014)

Effects of stent design on LDL accumulation at the carotid artery bifurcation
by: Nasrul Hadi, Johari, et al.
Published: (2019)

The Almost Everywhere Convergence of Eigenfunction Expansions of Schrödinger Operator in Lp Classes
by: N. A., Jamaludin, et al.
Published: (2017)

Weighted ergodic theorems for Banach–Kantorovich lattice Lp(∇ ,μ)
by: Mukhamedov, Farrukh, et al.
Published: (2013)

UMP and Indonesia’s Polytechnics LP31 forged strategic alliances
by: UMP, PNC

Compromise Fuzzy LP with Fuzzy Objective Function Coefficients and Fuzzy Constraints.
by: Susanto, S., et al.
Published: (2006)

Novel orlistat LDL-like nanoparticles as potential anti-cancer medicines
by: Bebawy, George
Published: (2022)

Oxidized-LDL and augmentation index among male organophosphate pesticides workers
by: Samsuddin, Niza, et al.
Published: (2012)

Polyphenols in Barringtonia racemosa and their protection against oxidation of LDL, serum and haemoglobin
by: Kong, Kin Weng, et al.
Published: (2014)

High-density lipoprotein subfractions - What the clinicians need to know
by: Pirillo, A., et al.
Published: (2013)

Treating high density lipoprotein cholesterol (HDL-C): Quantity versus quality
by: Pirillo, A., et al.
Published: (2013)

Postprandial lipemia as a cardiometabolic risk factor
by: Pirillo, A., et al.
Published: (2014)

Vascular inflammation and low-density lipoproteins: Is cholesterol the link? A lesson from the clinical trials
by: Catapano, A., et al.
Published: (2017)

Therapy and clinical trials: Aggressive statin therapy versus combined and emerging approaches
by: Catapano, A., et al.
Published: (2011)

Novel concepts in HDL pharmacology
by: Remaley, A., et al.
Published: (2014)

Niemann-pick C1-like 1 (NPC1L1) inhibition and cardiovascular diseases
by: Pirillo, A., et al.
Published: (2016)

HDLs, immunity, and atherosclerosis
by: Norata, Giuseppe, et al.
Published: (2011)

HDL in infectious diseases and sepsis
by: Pirillo, A., et al.
Published: (2015)

Targeting Cholesterol in Non-ischemic Heart Failure: A Role for LDLR Gene Therapy?
by: Catapano, A., et al.
Published: (2017)

Strategies for the use of nonstatin therapies
by: Pirillo, A., et al.
Published: (2017)

Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: Patient selection and perspectives
by: Catapano, A., et al.
Published: (2017)

Relationship between dyslipidaemia and glycaemic status in patients with type 2 diabetes mellitus
by: Chellappah Thambiah, Subashini, et al.
Published: (2016)

Targeting PCSK9 for hypercholesterolemia
by: Norata, Giuseppe, et al.
Published: (2014)

Statins and skeletal muscles toxicity: From clinical trials to everyday practice
by: Norata, Giuseppe, et al.
Published: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ah00df25duigtjiq8t5l747c44